Smruthi Organics Ltd. (SMRUTHIORG): Smruthi Organics Share Price Rises 9.15% Today as Micro Cap Stock Enters Top Gainers

Smruthi Organics Share Price Today rose 9.15% to Rs 127, taking the Healthcare micro cap with a market capitalisation of Rs 133.18 crore into focus.

Smruthi Organics Share Price moved sharply higher in Tuesday’s trade, rising 9.15% to Rs 127 from the previous close of Rs 116.35. With a market capitalisation of Rs 133.18 crore, Smruthi Organics Ltd. entered focus in Stock Market Today as a micro cap name that cleared the workflow’s qualifying price rise screen for its category. The stock opened at Rs 116.35, touched an intraday high of Rs 130.9, and held well above the day’s low of Rs 116.35 during the session.

For investors tracking Smruthi Organics Share Price Today, the verified data confirms a meaningful same-day gain backed by turnover of Rs 0.46 crore and traded volume of 36,573 shares on BSE. The supplied figures establish the price event clearly, although they do not establish a company-specific catalyst behind the move. That matters because Smruthi Organics Stock News today is being driven by measurable market action rather than any confirmed announcement within the provided dataset.

Why is the stock trending? The combination of a 9.15% share price gain, an intraday move from the opening level to Rs 130.9, and placement in a micro cap bracket naturally puts the counter among notable Market Movers and Top Gainers Today. Important financial metrics also add context: the company trades at a P/E ratio of 38.88 and a P/B ratio of 1.81, while ROE stands at 16.27% and ROCE at 21%. For readers using Univest for Smruthi Organics Share Price, the next step is to assess whether today’s price action aligns with its valuation, profitability and broader Pharmaceuticals & Drugs sector positioning.

Smruthi Organics Ltd. (SMRUTHIORG) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 127
Previous Close	Rs 116.35
Today's Change	+Rs 10.65 (+9.15%)
Day Open	Rs 116.35
Day High	Rs 130.9
Day Low	Rs 116.35
Current Volume (BSE)	36,573
BSE Traded Volume	36,573
Combined NSE + BSE Volume	36,573
Turnover	Rs 0.46 crore
Market Capitalisation	Rs 133.18 crore
Market Cap Category	Micro Cap

Smruthi Organics Ltd. (SMRUTHIORG) traded at Rs 127. versus the previous close of Rs 116.35, a rise of 9.15%. The stock opened at Rs 116.35, reached Rs 130.9, touched Rs 116.35. Reported volume was 36,573.

Smruthi Organics Ltd. (SMRUTHIORG) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 133.18 crore
P/E Ratio	38.88x
P/B Ratio	1.81x
ROE	16.27%
ROCE	21%
EPS	Rs 2.99
Dividend Yield	1.29%

Smruthi Organics Ltd. was valued at a P/E ratio of 38.88x, a P/B ratio of 1.81x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 16.27% and ROCE of 21%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 2.99, dividend yield of 1.29%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Smruthi Organics Share Price is drawing attention today, but the fundamental picture helps determine whether this is simply a market move or part of a broader valuation and profitability story. Based on the supplied data, the company remains a micro cap with a market capitalisation of Rs 133.18 crore. Its P/E ratio is 38.88 and its P/B ratio is 1.81, while return metrics stand at ROE of 16.27% and ROCE of 21%.

Those figures make Smruthi Organics Fundamental Analysis more nuanced than a simple momentum story. A P/E of 38.88 means investors are paying nearly 38.88 times earnings, which is not low in absolute terms. However, valuation cannot be judged in isolation. The P/B ratio of 1.81 is close to the industry median discussed later, which suggests the stock is not obviously stretched on book-value comparison. Profitability also deserves attention. ROE of 16.27% indicates that the company is generating a double-digit return on shareholder equity, while ROCE of 21% shows stronger returns on capital employed than the broader industry medians in the supplied benchmark set.

EPS is Rs 2.99, a relevant anchor for understanding the earnings base behind Smruthi Organics Share Price. In simple terms, this represents the earnings attributable to each share. Dividend yield is 1.29, which provides historical payout context relative to the current stock price. That yield is not a future promise, but it does show the stock is not purely a no-payout micro cap story. Together, EPS of Rs 2.99 and dividend yield of 1.29 add balance to the discussion around valuation and shareholder return profile.

For investors following Smruthi Organics Stock Analysis on Univest, the key takeaway is that the company combines a moderate-to-higher earnings multiple with respectable return ratios. That mix can support interest when a stock enters Stocks in News, but it also means that today’s price rise should be read alongside relative valuation, not apart from it. The next layer, therefore, is to compare Smruthi Organics Share Price with the sector and industry benchmarks supplied in the dataset.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	38.88x
Benchmark Median P/E	26.3x
Benchmark Average P/E	80.76x
Benchmark P/E Range	3.21x to 3,417.8x
Company P/B Ratio	1.81x
Benchmark Median P/B	1.83x
Company ROE	16.27%
Benchmark Median ROE	9.93%
Company ROCE	21%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 133.18 crore
Benchmark Median Market Cap	Rs 142.44 crore

Smruthi Organics Ltd. (SMRUTHIORG) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Smruthi Organics Ltd. (SMRUTHIORG) has a P/E ratio of 38.88x, which is above the benchmark median of 26.3x, a difference of +47.83%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Smruthi Organics Ltd. (SMRUTHIORG) has a ROE of 16.27%, which is above the benchmark median of 9.93%, a difference of +63.85%. Smruthi Organics Ltd. (SMRUTHIORG) has a ROCE of 21%, which is above the benchmark median of 12.96%, a difference of +62.04%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Smruthi Organics Share Price is best understood within its Healthcare sector and Pharmaceuticals & Drugs industry backdrop. The supplied sector snapshot compares the company with a same-industry benchmark universe of 140 companies, allowing a more grounded reading of valuation and profitability.

Within this same-industry benchmark, Smruthi Organics trades at a P/E ratio of 38.88. That is above the benchmark median P/E of 26.3, but below the benchmark average P/E of 80.76. The range itself is very wide, from 3.21 to 3417.8 across 104 companies with P/E data, which shows how dispersed valuations are in this segment. That context matters: Smruthi Organics Share Price is not among the lowest-valued names on earnings, yet it is also far below the extreme upper end of the industry range.

On P/B, the company stands at 1.81. That is fractionally below the benchmark median P/B of 1.83 and well below the benchmark average of 2.92 across 139 companies. The broader P/B range runs from -16 to 59.75, again highlighting wide variation among listed Pharmaceuticals & Drugs companies. Relative to that set, Smruthi Organics appears closer to the centre on book-value valuation than on earnings valuation.

Profitability comparisons are more favourable. Company ROE is 16.27%, above the benchmark median ROE of 9.93% and also above the benchmark average of 7.45. ROCE at 21% is similarly stronger than the benchmark median of 12.96% and average of 14.33. In market-cap terms, Smruthi Organics at Rs 133.18 crore sits slightly below the industry median market capitalisation of Rs 142.44 crore and well below the average of Rs 489.44 crore. The full market-cap range spans Rs 2.09 crore to Rs 3,032.97 crore. For readers using Univest to follow Smruthi Organics Share Price, this sector view suggests a smaller company with return ratios that compare well to many industry names, even if its earnings multiple sits above the median.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,531.49	0	3.03	0	5.36

Smruthi Organics Ltd. (SMRUTHIORG) has a P/E ratio of 38.88x compared with the displayed peer median of 31.12x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.27% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 21% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Smruthi Organics Ltd. (SMRUTHIORG) has a market capitalisation of Rs 133.18 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Smruthi Organics Share Price also becomes more understandable when compared with listed peers in the same Healthcare and Pharmaceuticals & Drugs space. The supplied peer set includes companies such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Panacea Biotec, Sai Parenteral’s, Solara Active Pharma Sciences, NGL Fine-Chem, Venus Remedies and Hester Biosciences.

On market capitalisation, Smruthi Organics at Rs 133.18 crore is much smaller than all listed peers in the supplied group, where the lowest peer market cap shown is Hester Biosciences at Rs 2,057.85 crore and the highest is Dishman Carbogen Amcis at Rs 3,032.97 crore. That underlines the stock’s micro cap positioning in a peer basket dominated by materially larger companies.

In valuation terms, Smruthi Organics trades at a P/E of 38.88. That is higher than Dishman Carbogen Amcis at 31.12, Venus Remedies at 17.81 and Hester Biosciences at 15.11, but lower than Kwality Pharmaceuticals at 40.2, Beta Drugs at 63.43, NGL Fine-Chem at 44.02 and Sai Parenteral’s at 176.28. Hikal, Panacea Biotec and Solara Active Pharma Sciences do not have P/E values in the supplied peer data, so the relative reading here comes from the available figures only.

On P/B, Smruthi Organics at 1.81 sits above Dishman Carbogen Amcis at 0.45 but below Hikal at 2.35, Panacea Biotec at 3.03, Sai Parenteral’s at 3.26, Hester Biosciences at 4.52, Beta Drugs at 6.27, NGL Fine-Chem at 6.43 and Kwality Pharmaceuticals at 8.18. Solara at 1.9 is very close. Profitability is competitive as well. Smruthi Organics ROE of 16.27% is above Hikal’s 15.22%, Venus Remedies’ 9.85%, Sai Parenteral’s 13.9%, Panacea Biotec’s 0% and Dishman Carbogen Amcis’ negative 2.89%, while below Kwality Pharmaceuticals, Beta Drugs, NGL Fine-Chem and Solara. ROCE of 21% is stronger than Hikal, Solara, Hester Biosciences, Venus Remedies, Panacea Biotec, Sai Parenteral’s and Dishman Carbogen Amcis, though below Beta Drugs, Kwality Pharmaceuticals and NGL Fine-Chem. This makes Smruthi Organics Share Price interesting from a relative-efficiency standpoint despite its much smaller scale.

Why Investors Are Watching Smruthi Organics

Smruthi Organics Share Price is on investor radar because today’s move combines a visible price rise with a financial profile that is neither purely speculative nor obviously cheap. In Market News terms, the stock has become a top gainer in its size category, while its profitability and valuation metrics offer enough substance to justify closer tracking.

• Verified price action: The stock rose 9.15% from Rs 116.35 to Rs 127, after opening at Rs 116.35 and touching Rs 130.9 intraday.
• Trading activity: BSE volume stood at 36,573 shares and turnover reached Rs 0.46 crore, confirming active participation in today’s move.
• Fundamental context: Smruthi Organics Share Price is backed by P/E of 38.88, P/B of 1.81, ROE of 16.27%, ROCE of 21%, EPS of Rs 2.99 and dividend yield of 1.29.
• Sector positioning: P/E is above the industry median of 26.3, but P/B is slightly below the median of 1.83, while ROE and ROCE are above benchmark medians.
• Scale factor: The company remains a micro cap at Rs 133.18 crore, much smaller than the supplied listed peers.

What should investors monitor next? At this stage, the most useful markers are whether Smruthi Organics Share Price can hold a meaningful part of today’s gain, how its valuation compares with subsequent peer moves, and whether future company updates provide a stock-specific explanation for the interest seen in today’s session. Univest readers tracking Momentum Stocks should keep the focus on confirmed data rather than assumptions.

About Smruthi Organics

Smruthi Organics Ltd. is positioned within the Healthcare sector and the Pharmaceuticals & Drugs industry. That places the company in a business segment where listed entities are commonly assessed on valuation, profitability, and capital efficiency, especially because peer groups often contain a wide spread of market capitalisations and financial multiples.

In the context of Smruthi Organics Share Price, the available dataset supports a straightforward company overview rather than a broad corporate profile. The company operates in pharmaceuticals-related activity as captured under Pharmaceuticals & Drugs, and its listed market presence is relatively small compared with the larger healthcare peers included in the benchmark set. At Rs 133.18 crore in market capitalisation, it sits close to the industry median market cap but far below the upper end of the sector’s listed players, which extends above Rs 3,000 crore in the supplied sample.

This smaller scale is important for interpreting Smruthi Organics Share Price Today. Micro cap stocks can become Stocks in News quickly when a single session brings a sizeable move, but scale alone does not define quality. In Smruthi Organics’ case, the supplied financial ratios show a company that combines modest size with return metrics above industry medians. That makes it a name worth watching for investors interested in smaller listed healthcare businesses. On Univest, readers can place Smruthi Organics Share Price within a more complete stock analysis framework by comparing price moves with sector metrics, peer ratios and ongoing market updates.

Track Smruthi Organics Share Price on Univest

Use Smruthi Organics Ltd. (SMRUTHIORG) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who want to follow Smruthi Organics Share Price more closely can use Univest to monitor live share price movements, valuation ratios, profitability metrics and broader stock performance data in one place. That includes Smruthi Organics Share Price Today, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, dividend yield and 52-week level tracking when available in platform data.

Univest also helps readers compare Smruthi Organics Stock News with peer companies, sector benchmarks and other Stocks Rising Today across the Indian Stock Market. For users filtering Market Movers or Top Gainers Today, that broader context can be useful in separating a single-session price rise from a more data-backed stock story. The goal is not to make a recommendation, but to keep Smruthi Organics Share Price visible within verified, comparable and regularly updated market information.

Frequently Asked Questions

What is Smruthi Organics Share Price today?

Ans. Smruthi Organics Share Price today was Rs 127 at the time of the event snapshot. The stock had closed previously at Rs 116.35, so the session reflected a meaningful single-day move in this micro cap healthcare company.

Why is Smruthi Organics Share Price rising today?

Ans. The supplied data confirms that Smruthi Organics Share Price rose 9.15% today, supported by trading volume of 36,573 shares and turnover of Rs 0.46 crore on BSE. The dataset confirms the move, but does not identify a company-specific catalyst.

How much did Smruthi Organics stock gain in today's trade?

Ans. Smruthi Organics stock gained Rs 10.65 in today’s trade, rising 9.15% from the previous close of Rs 116.35 to Rs 127. The stock also touched an intraday high of Rs 130.9 during the session.

What were the day high, day low and opening price for Smruthi Organics?

Ans. Smruthi Organics opened at Rs 116.35, touched a day high of Rs 130.9 and recorded a day low of Rs 116.35. That shows the stock held its opening level and moved higher during the session.

What is the market capitalisation of Smruthi Organics?

Ans. Smruthi Organics has a market capitalisation of Rs 133.18 crore based on the supplied data. That places it in the Micro Cap category and explains why today’s 9.15% share price rise attracted screening-based market attention.

Is Smruthi Organics expensive based on its valuation ratios?

Ans. Smruthi Organics trades at a P/E of 38.88, above the same-industry median of 26.3, while its P/B of 1.81 is slightly below the industry median of 1.83. That suggests mixed valuation signals rather than a one-sided conclusion.

How profitable is Smruthi Organics compared with its industry benchmark?

Ans. Smruthi Organics reported ROE of 16.27% and ROCE of 21%. Both are above the same-industry benchmark medians of 9.93% for ROE and 12.96% for ROCE, indicating stronger profitability than many listed peers in the sample.

What are the key fundamental metrics for Smruthi Organics?

Ans. Key metrics for Smruthi Organics include P/E of 38.88, P/B of 1.81, ROE of 16.27%, ROCE of 21%, EPS of Rs 2.99 and dividend yield of 1.29. Together, these provide valuation and profitability context for today’s move.

Which sector and industry does Smruthi Organics belong to?

Ans. Smruthi Organics belongs to the Healthcare sector and operates within the Pharmaceuticals & Drugs industry. The benchmark comparison in the supplied data covers 140 companies from the same industry, giving useful context for valuation and returns.

How does Smruthi Organics compare with listed pharma peers?

Ans. Smruthi Organics is much smaller than peers such as Hikal, Beta Drugs and Hester Biosciences on market capitalisation, but its ROE of 16.27% and ROCE of 21% compare favourably with several companies in the supplied peer set.